A $21 million jury award for defective designs of Biomet’s M2A Magnum metal-on-metal hip implant has been announced by a federal judge. This lawsuit is the result of a complex investigation into Zimmer Biomet’s M2A Magnum hip implant. The device is accused of several flaws, including its lack of a periprosthetic sleeve.
In October 2012, a federal judicial panel consolidated dozens of lawsuits related to Biomet M2A Magnum hip implants. MDLs allow law firms to pool their resources and level the playing field. In the Biomet M2A Magnum hip implant lawsuit, patients claim that the metal parts of the device released microscopic metal ions into their blood. These metal particles are harmful to the body and can cause several complications, including metallosis, a condition where small particles of metal are released into the bloodstream.
The Biomet M2A Magnum hip replacement system is made of all metal surfaces. Because of this, the metal surfaces make contact with each other during patient movement. This can cause significant injuries, and in some cases, requires revision surgery. The company may have been negligent in its efforts to increase profits by reducing the risks associated with the devices, which triggered thousands of lawsuits.
Numerous complaints about the Biomet M2A Magnum hip implant have resulted in dozens of lawsuits and hundreds of formal complaints. Patients have reported a wide variety of complications and pain, including metal poisoning, ALVAL, bone loss, and disfigurement. Some patients have even experienced pain and disability that required revision surgery, and they are now seeking compensation for these injuries and damages.
The main complications associated with the Biomet M2A Magnum hip implant are metallosis and loosening. This metal-on-metal joint is composed of a titanium outer acetabular shell and a cobalt alloy metallic bearing. Although these metals are relatively strong, they are not impervious to the development of corrosion, and may become loose over time. Patients may experience pain and discomfort, or hear an audible popping sound.
Metallosis is another potential risk associated with the Biomet M2A Magnum hip implant. This metal-on-metal hip implant can cause metallosis, a condition in which toxic amounts of cobalt and chromium are released into the body. When these metals accumulate in the bloodstream, they can cause tissue and organ damage and even small tumors. Patients with metallosis should contact a hip implant attorney as soon as possible.
Numerous lawsuits have been filed against Biomet for the M2A Magnum and M2a-38 metal on metal hip implants. Several patients have suffered from metallosis, ALVAL, heart damage, and even pseudotumors. Some patients have undergone horrific revision surgeries to correct the problems. Fortunately, there are attorneys who specialize in filing such lawsuits and reviewing medical records. The following is a list of some of the injuries suffered by patients and how they were able to seek compensation.
Many of the plaintiffs in Biomet M2A Magnum hip implant litigation are former Biomet patients. The lawsuits claim that the biomet implant failed prematurely and was causing metallosis. Patients have also suffered pain and disability because of metal toxicity that was not adequately controlled. A defective metal-on-metal hip implant may result in a lifetime of pain and disability. If you suffered from any of these symptoms, you should consult with a biomet M2A Magnum hip implant attorney to pursue compensation.
The U.S. District Court for the Eastern District of Missouri recently approved a $21 million verdict against Zimmer Biomet Inc. for the defective M2a Magnum metal-on-metal hip implant. The company was accused of the faulty design of the implant, which is prone to failure and loosening. The award, however, is a win for the victims of Biomet. The plaintiffs’ attorneys are praising the court for holding an in-person trial.
The Covid-19 pandemic has led to a growing number of mental hip replacement cases being brought to court. In recent years, juries have awarded significant verdicts in the lawsuits filed against Biomet. Two recent Biomet M2A Magnum cases have resulted in substantial verdicts for plaintiffs. Biomet is currently appealing the verdicts. It is unclear whether it will settle future cases.